PMID: 16505554Mar 1, 2006Paper

Nosocomial infections due to Acinetobacter species: Clinical findings, risk and prognostic factors

Indian Journal of Medical Microbiology
K Prashanth, S Badrinath

Abstract

Nosocomial infections caused by Acinetobacter species is of increasing concern in critically ill patients, and the risk factors for this infection are not well established. The present investigation was done to determine incidence of nosocomial Acinetobacter infections. Our study retrospectively attempts to find risk and prognostic factors for the nosocomial acquisition of Acinetobacter infection. The medical records of 43 patients with Acinetobacter infection during two-year period (Oct1998-Oct2000) were reviewed to find the factors involved in the nosocomial acquisition of Acinetobacter. Acinetobacter isolates that were obtained from these patients were phenotypically typed using carbon assimilation tests. Antimicrobial susceptibility testing results were noted from the microbiology records. Acinetobacter baumannii accounted for 41.8% (n=18) of all the infections. By multivariate logistic regression analysis, only resistant antibiotype {(Ceftazidime- OR, 7.13 [95% CI, 1 to 46];p= 0.044); (Cefotaxime- OR, 6.09 [CI, 0.87 to 30];p = 0.045)} and mechanical ventilation (OR, 5.84 [CI, 0.83 to 31];p = 0.05) were found to be potential independent risk factors for mortality. Overall mortality rate was 33%. Most of A. baumannii isolate...Continue Reading

Citations

Jun 17, 2010·Indian Journal of Pathology & Microbiology·Sanjay Bhattacharya
Apr 20, 2013·Journal of Global Infectious Diseases·Anuradha S DeMeenakshi M Mathur
Dec 21, 2007·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Nozha BrahmiMouldi Amamou
Jan 16, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Abdel Moati Kh Al JaroushaIyad A El Qouqa
Jul 6, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M E FalagasUNKNOWN Greek System for Surveillance of Antimicrobial Resistance
Mar 3, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M M WroblewskaM Luczak
May 11, 2018·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·M MahendraP A Mahesh
Jan 29, 2020·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Sneha S Savanur, Hemamalini Gururaj

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Nan-Yao LeeWen-Chien Ko
Journal of Infection in Developing Countries
Noyal Mariya JosephSubhash Chandra Parija
© 2021 Meta ULC. All rights reserved